Social networks
826Activities
Technologies
Entity types
Location
Middelweg 38b, 2312 KJ Leiden, Netherlands
Leiden
Netherlands
Employees
Scale: 2-10
Estimated: 25
Engaged corporates
0Added in Motherbase
1 year, 2 months agoVarmX is a young biotech company focusing on the development of therapies in the field of hemostasis and thrombosis.
VarmX (www.varmx.com) is a young Leiden based biotech company that is focusing on the development of therapies in the field of hemostasis and thrombosis. Originally a spin-off from the Leiden University Medical Center (LUMC), our mission is to develop and manufacture therapeutic proteins to restore hemostasis. Our lead compound, VMX-C001, is intended to safely and effectively restore hemostasis in case of bleeding or emergency surgery in patients taking so-called oral factor Xa inhibitors. The VarmX program has gained significant interest in the investment community and a very successful Series B financing round of €32 mill. was closed in 2020.
This round was followed by a Series B2 round of €32 mill. in May 2023 allowing the company to further progress the lead program towards Investigational New Drug (IND) approval and prepare for pivotal trials.
anti-coagulant inhibitors, Hemostasis, Thrombosis, FXa inhibitors, and DOACs